Jansen's metaphyseal chondrodysplasia
This article needs additional citations for verification. (April 2017) |
Jansen's metaphyseal chondrodysplasia | |
---|---|
Other names | Murk Jansen-type metaphyseal chondrodysplasia, Jansen metaphyseal dysostosis, Jansen disease |
autosomal dominant manner. |
Jansen's metaphyseal chondrodysplasia (JMC) is a disease that results from
JMC is extremely rare, and as of 2007 there are fewer than 20 reported cases worldwide. There are only 2 known families, from Dubai and Texas, in which the disease was passed from mother to daughter (Texas), and from a mother to her 2 sons (Dubai).[1]
Presentation
Blood levels of
Physical irregularities often associated with Jansen's include: prominent or protruding eyes, a
Cause
Jansen's metaphyseal chondrodysplasia is caused by a mutation in the
Diagnosis
Diagnosis typically occurs during infancy or early childhood and is based around physical characteristics and symptoms.
Treatment
There is no known treatment at present, although some investigators have tried to lessen the hypercalcemia with various forms of
Eponym
It is named for Murk Jansen (1867–1935), a Dutch orthopedic surgeon.[3][4]
References
- ^ Luxner, Larry (20 August 2019). "Nebraska's Neena Nizar Seeks Cure for Jansen's, One of World's Rarest Diseases". Huntington Disease News. Retrieved 16 December 2020.
- ^ a b "Jansen Type Metaphyseal Chondrodysplasia - NORD (National Organization for Rare Disorders)". NORD (National Organization for Rare Disorders). Retrieved 2018-03-16.
- ^ Jansen, M. Ueber atypische Chondrodystrophie (Achondroplasie) und ueber eine noch nicht beschriebene angeborene Wachstumsstoerung des Knochensystems: Metaphysaere Dysostosis. Z. Orthop. Chir. 61: 253-286, 1934.
- S2CID 23466423.
Further reading
- Metaphyseal chondrodysplasia, Jansen type -- OrphaNet Information (PDF) Archived 2022-05-03 at the Wayback Machine
- Jansen’s Metaphyseal Chondrodysplasia, Case Report, Indian Pediatrics
- Jansen Type Metaphyseal Chondrodysplasia -- National Organization for Rare Disorders (NORD)
- A Novel Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Mutation in Jansen’s Metaphyseal Chondrodysplasia, The Journal of Clinical Endocrinology & Metabolism (1) Archived 2011-05-16 at the Wayback Machine
- A Form of Jansen’s Metaphyseal Chondrodysplasia with Limited Metabolic and Skeletal Abnormalities Is Caused by a Novel Activating Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Mutation, The Journal of Clinical Endocrinology & Metabolism (2) Archived 2011-05-16 at the Wayback Machine
- Constitutively Activated Receptors for Parathyroid Hormone and Parathyroid Hormone–Related Peptide in Jansen's Metaphyseal Chondrodysplasia, The New England Journal of Medicine
- Constitutive Activation of the Cyclic Adenosine 3',5'-Monophosphate Signaling Pathway by Parathyroid Hormone (PTH)/PTH-Related Peptide Receptors Mutated at the Two Loci for Jansen’s Metaphyseal Chondrodysplasia, Molecular Endocrinology Archived 2008-08-29 at the Wayback Machine